Featured MM&M Awards Sponsor




Ogilvy CommonHealth Worldwide, part of the Ogilvy & Mather network and a WPP Company, is the single most innovative, resourceful—and largest—healthcare communications network in the world, with 64 offices across 33 countries. Ogilvy CommonHealth Worldwide provides 360-degree marketing services including advertising and promotion, brand identity and development, global integration, direct-to-consumer, direct-to-patient, relationship marketing, digital/interactive services, managed care marketing, medical education, media planning and buying, clinical trial recruitment, market research and analytics, strategic consulting and public affairs and relations. The organization houses individual Ogilvy CommonHealth and Ogilvy Healthworld brand identities and numerous partnerships both within and outside the networks of the Ogilvy & Mather and WPP companies.

SUBSCRIBE TO MM&M


MM&M 
offers the most relevant news, analysis, opinion, feature stories and special reports to nearly 15,000 marketing executives at pharma companies, agencies and in healthcare media. Click here to subscribe.

THE INTERACTIVE GUIDE


Click here to read the MM&M 2013 Game Changers issue, with a report on trends that are changing the industry and a showcase of companies at the forefront of this transition.

2011/12 Pharmaceutical Marketers Directory


NOW FULLY
SEARCHABLE ONLINE
UPDATED MONTHLY @ ThePMD.com
Over 6,000 new names, and 20,000 business connections. From the industry's trusted resource for over 34 years. Now find what you need even quicker and easier with the searchable online edition.

Get connected today and order your personal copy and free online access!

The MM&M News Brief provides news and features delivered direct to your inbox. To access the full text, simply click the headline.

Latest News

Consumers may be savvier, less fearful about online privacy and advertising than you think

Consumers are as worried about online privacy as they are about terrorism, but marketers tracking their surfing habits or mining their emails for insights is the least of their worries, according to a survey by McCann Truth Central.
 

Kramer to retire as CEO of Digitas, Razorfish health shops

David Kramer, who co-founded the agency now known as Digitas Health in 1988 and led the shop through two mergers and a recent reorganization, announced that he will leave the company at year's end.
 

Boehringer's Pharma-ville could salve industry's bad reputation

Boehringer Ingelheim is hoping to create a new Facebook phenomenon with the development of a pharma civilization game that could give industry reputation a shot in the arm.
 

Branded Benlysta DTC campaign ready to roll out

New online and print DTC advertising targeting US patients with lupus will appear "within weeks," said executives from Human Genome Sciences. Can the campaign revive blockbuster fortunes for Benlysta?
 



Why is Regional Marketing So Hot? Audience will learn how regional marketing can benefit your brand's position; how to make regional marketing simple and executable; and the value of a district level driver analysis and how this can become the foundation of regional marketing intelligence.

In Brief

Company news: Pfizer and PatientsLikeMe

Pfizer canned an online ad for ChapStick after bloggers panned it as sexist, The Wall Street Journal reported.
 

LATEST FEATURES

Tailor-Made Marketing

Aided by the digital revolution, patient marketing programs get increasingly personal, with more customization aimed at differentiating products and keeping patients on therapy, Matthew Arnold reports
 

Who's Really Putting Patients First?

"Patient-centric" may be the buzz, but who's really inspiring better health choices? Alyson Connor shares findings from the behaviorists at MicroMass Communications
 

Therapeutic Focus: Oncology

Targeted therapies have opened doors to tumor control. As drugmakers aim for more focused patient groups, realistic expectations on pricing and revenue potential are proving elusive, finds Noah Pines
 

Back to the Books

The comeback continues. Professional journal advertising climbed in first-half 2011, driven by new and mature products. Marc Iskowitz on the biggest advertisers and most advertised brands
 

Leading Latuda through the crowd

Mark Iwicki's top priority is driving the success of Latuda, an atypical antipsychotic for adults with schizophrenia.
 




Advertise
For details on how to advertise in MM&M News Brief, please email Doreen Gates

Unsubscribe
To unsubscribe from the MM&M News Brief click here.
To manage your entire MM&M profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All MM&M newsletters are sent from the domain "email.mmm-online.com". When configuring e-mail or spam
filter rules, please use this domain name.

Medical Marketing & Media Magazine
114 W. 26th Street 4th Floor
New York N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150
http://www.mmm-online.com/

© 2013 Haymarket Media Inc.